Latest Publications
-
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers